Fasudil inhibits the myogenic response in the fetal pulmonary circulation
Authors:
- 1 October 2008
- journal article
- research article
- Published by American Physiological Society in American Journal of Physiology-Heart and Circulatory Physiology
- Vol. 295 (4) , H1505-H1513
Abstract
In addition to high pulmonary vascular resistance (PVR) and low pulmonary blood flow, the fetal pulmonary circulation is characterized by mechanisms that oppose vasodilation. Past work suggests that high myogenic tone contributes to high PVR and may contribute to autoregulation of blood flow in the fetal lung. Rho-kinase (ROCK) can mediate the myogenic response in the adult systemic circulation, but whether high ROCK activity contributes to the myogenic response and modulates time-dependent vasodilation in the developing lung circulation are unknown. We studied the effects of fasudil, a ROCK inhibitor, on the hemodynamic response during acute compression of the ductus arteriosus (DA) in chronically prepared, late-gestation fetal sheep. Acute DA compression simultaneously induces two opposing responses: 1) blood flow-induced vasodilation through increased shear stress that is mediated by NO release and 2) stretch-induced vasoconstriction (i.e., the myogenic response). The myogenic response was assessed during acute DA compression after treatment with Nω-nitro-l-arginine, an inhibitor of nitric oxide synthase, to block flow-induced vasodilation and unmask the myogenic response. Intrapulmonary fasudil infusion (100 μg over 10 min) did not enhance flow-induced vasodilation during brief DA compression but reduced the myogenic response by 90% ( P < 0.05). During prolonged DA compression, fasudil prevented the time-dependent decline in left pulmonary artery blood flow at 2 h (183 ± 29 vs. 110 ± 11 ml/min with and without fasudil, respectively; P < 0.001). We conclude that high ROCK activity opposes pulmonary vasodilation in utero and that the myogenic response maintains high PVR in the normal fetal lung through ROCK activation.Keywords
This publication has 52 references indexed in Scilit:
- Rho kinase and Ca2+entry mediate increased pulmonary and systemic vascular resistance inl-NAME-treated ratsAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2007
- Rho Kinase–Mediated Vasoconstriction Is Important in Severe Occlusive Pulmonary Arterial Hypertension in RatsCirculation Research, 2007
- Long-term inhibition of Rho kinase with fasudil attenuates high flow induced pulmonary artery remodeling in ratsPharmacological Research, 2007
- Long-Term Inhibition of Rho-kinase Ameliorates Hypoxia-Induced Pulmonary Hypertension in MiceJournal of Cardiovascular Pharmacology, 2006
- Rho kinase activation maintains high pulmonary vascular resistance in the ovine fetal lungAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2006
- Inhibition of 20-HETE abolishes the myogenic response during NOS antagonism in the ovine fetal pulmonary circulationAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2005
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- Recent developments in the pathophysiology and treatment of persistent pulmonary hypertension of the newbornThe Journal of Pediatrics, 1995
- Time-dependent response of fetal pulmonary blood flow to an increase in fetal oxygen tensionRespiration Physiology, 1986
- Persistent pulmonary hypertension of the newborn infantThe Journal of Pediatrics, 1976